Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man

References
1 Chartrand NA, Lau CK, Parsons MT. et al. Ocular Side Effects of Bisphosphonates: A Review of Literature. J Ocul Pharmacol Ther 2023; 39: 3-16
2 [Anonymous] Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Last Update May 4, 2019. Accessed December 19, 2023 at: https://www.ncbi.nlm.nih.gov/books/NBK548069/
3 Etiman M, Forooghian F, Maberley D. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study. CMAJ 2012; 184: e431-e434
4 French DD, Margo CE. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina 2008; 28: 889-893
5 Keren S, Leibovitch I, Ben Cnaan R. et al. Aminobisphosphonate-associated orbital and ocular inflammatory disease. Acta Ophthalmol 2019; 97: e792-e799
6 Rifkin LM. Posterior Scleritis: A Diagnostic Challenge. Rev Ophthalmol, published 9 February 2018. Accessed December 19, 2023 at: https://www.reviewofophthalmology.com/article/posterior-scleritis-a-diagnostic-challenge
7 Leung S, Ashar BH, Miller RG. Biphosphonate-associated scleritis: a case report and review. South Med J 2005; 98: 733-735